Investigated event: Influence on protein activity - MAPK signalling
| Name | Value |
|---|---|
| Compound | Napabucasin |
| Investigated event | Influence on protein activity - MAPK signalling |
| Experiment type | Western Blot |
| Concentration | 1.50 µM |
| Cell line | SUDHL-4 |
| Organism | Homo sapiens |
| Animal model | |
| STAT protein | |
| Other | p-p38 |
Reference
Napabucasin, a novel inhibitor of STAT3, inhibits growth and synergises with doxorubicin in diffuse large B-cell lymphoma. Cancer letters Xue Li, Yuquan Wei, Xiawei Wei, 491, None, 2020-10-28, 2020-08-14, 10.1016/j.canlet.2020.07.032
DOI: 10.1016/j.canlet.2020.07.032
PUBMED: 32798587
PMCID: 32798587